Ironwood Pharmaceuticals Inc

Ownership Transactions Reported by 17 Insiders

Symbol
IRWD on Nasdaq
Location
100 Summer Street, Suite 2300, Boston, MA

Insiders trading volume in the past year

Ironwood Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Alexander J. Denner Director, 10%+ Owner $104M Jun 18, 2024
Thomas A. MCCOURT Chief Executive Officer, Director $7.42M -$3.14M -29.7% May 20, 2024
Jason Rickard SVP, Chief Operating Officer $4.21M Mar 8, 2023
Mark G. Currie Director $3.58M Jun 18, 2024
Edward P. Owens Director $3.15M Jun 2, 2021
Michael Shetzline CMO,SVP,Head-Res&Drug $2.67M -$693K -20.6% May 20, 2024
Sravan K. Emany SVP, Chief Financial Officer $2.13M +$400K +23.2% May 16, 2024
Andrew Davis SVP, Chief Business Officer $1.86M -$328K -15% May 20, 2024
Minardo John Chief Legal Officer $1.22M -$877K -41.9% Aug 12, 2024
Andrew Dreyfus Director $1.18M Jun 18, 2024
Julie McHugh Director $1.03M -$143K -12.2% Jun 18, 2024
Lawrence S. Olanoff Director $1.02M Jun 2, 2021
Jon R. Duane Director $914K +$60.2K +7.05% Jun 18, 2024
Jay Shepard Director $796K Jun 18, 2024
Marla L. Kessler Director $760K -$111K -12.7% Jun 18, 2024
Ronald Silver Principal Accounting Officer $676K -$134K -16.5% Aug 12, 2024
Catherine Moukheibir Director $459K -$518K -53% Jun 18, 2024

Recent Insider Transactions by Companies or Individuals for Ironwood Pharmaceuticals Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.